Shire PLC (LON:SHP) shares shot up 3.2% during trading on Monday . The company traded as high as GBX 3,921 ($52.01) and last traded at GBX 3,909 ($51.85). 1,776,841 shares traded hands during trading, a decline of 31% from the average session volume of 2,569,750 shares. The stock had previously closed at GBX 3,788 ($50.25).

A number of equities research analysts have recently weighed in on the company. Liberum Capital reiterated a “hold” rating and issued a GBX 4,900 ($65.00) price objective on shares of Shire PLC in a research report on Thursday, August 3rd. Deutsche Bank AG reduced their target price on Shire PLC from GBX 6,000 ($79.59) to GBX 5,700 ($75.61) and set a “buy” rating on the stock in a research note on Tuesday, September 5th. J P Morgan Chase & Co restated an “overweight” rating on shares of Shire PLC in a report on Friday, August 4th. Credit Suisse Group reaffirmed an “outperform” rating and issued a GBX 5,350 ($70.96) price target on shares of Shire PLC in a research note on Tuesday, August 22nd. Finally, Barclays PLC reaffirmed an “overweight” rating and issued a GBX 6,300 ($83.57) price target on shares of Shire PLC in a research note on Tuesday, June 27th. Four research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of GBX 5,837.29 ($77.43).

The stock’s market cap is GBX 35.43 billion. The stock has a 50-day moving average price of GBX 3,846.08 and a 200 day moving average price of GBX 4,306.46.

The company also recently announced a dividend, which will be paid on Friday, October 20th. Shareholders of record on Thursday, September 7th will be paid a GBX 3.85 ($0.05) dividend. The ex-dividend date is Thursday, September 7th. This represents a yield of 0.1%.

In other Shire PLC news, insider Flemming Ornskov purchased 8,400 shares of the firm’s stock in a transaction on Tuesday, August 22nd. The stock was bought at an average cost of GBX 3,665 ($48.61) per share, for a total transaction of £307,860 ($408,356.55).

WARNING: “Shire PLC (SHP) Shares Up 3.2%” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://www.thecerbatgem.com/2017/10/02/shire-plc-shp-shares-up-3-2.html.

Shire PLC Company Profile

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Receive News & Stock Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related stocks with our FREE daily email newsletter.